GOLDBUG STRATEGIES LLC for GENOMIC HEALTH INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHEILA D WALCOFF | Committee, US House Of Representatives |
Medical/Disease Research/Clinical Labs MED
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHEILA D WALCOFF | Committee, US House Of Representatives |
Health Issues HCR
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHEILA D WALCOFF | Committee, US House Of Representatives |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.